T1	Participants 84 143	men with signs and symptoms of benign prostatic hyperplasia
T2	Participants 372 507	Men 50 years or older with an International Prostate Symptom Score of 13 or greater and peak urinary flow rate of 4 to 15 ml per second
T3	Participants 810 884	Of 923 patients (mean age 65 years) 466 received silodosin and 457 placebo
